The LDN 2026 Virtual Conference Recordings is designed to provide high-quality, evidence-based continuing medical education through a comprehensive series of on-demand presentations.

This virtual format allows participants to engage with educational content at a time and location that best accommodates their clinical and professional commitments.

An application for Continuing Medical Education (CME) credits will be submitted.

The program will feature presentations by experienced clinicians and subject-matter experts with clinical and research expertise in Low-Dose Naltrexone (LDN).

Faculty: Click Here

Learning Objectives

Upon completion of this educational activity, participants should be able to:


• Explain the proposed mechanisms of action of Low-Dose Naltrexone, including its
immunomodulatory and neuroinflammatory effects

• Assess the current evidence base for the use of LDN in selected chronic and complex medical conditions
• Identify appropriate patient selection criteria, dosing considerations, contraindications, and safety issues related to LDN therapy
• Integrate evidence-based and practical considerations into clinical decision-making and patient management involving LDN
• Price $799

Members receive a 30% Discount